The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis
- 2 January 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in Acta Clinica Belgica
- Vol. 71 (1), 1-8
- https://doi.org/10.1080/17843286.2015.1110894
Abstract
Background: Accelerating atherosclerosis in type 2 diabetes mellitus (T2DM) patients may relate to imbalance between pattern of microparticles (MPs), which are frequently involved in repair of vasculature, tissue injury, inflammation and thrombosis. The aim of the study was to investigate the pattern of circulating MPs in T2DM patients with asymptomatic atherosclerosis. Methods: A total of 103 patients with T2DM (54 subjects without documented coronary atherosclerosis and 49 patients with angiographic evidence of asymptomatic coronary atherosclerosis) who were underwent a contrast-enhanced multispiral computed tomography angiography and 35 healthy volunteers were enrolled in the study. To determine circulating biomarkers, blood samples were collected at baseline. MPs were labelled and characterized by flow cytometry. Results: There were no significant differences between healthy volunteers and T2DM patients in circulating numbers of MPs labelled as CD41a+, CD64+, CD144+, CD144+/CD31+, Annexin V+, CD144+/annexin V+ and CD144+/CD31+/annexin V+. However, lower number of MPs with immune phenotypes CD62E+, CD105E+ and higher numbers of CD31+/annexin V+ MPs were reported in T2DM patients when compared with healthy volunteers. Therefore, we found an increased level of circulating CD41a+ MPs, CD144+/CD31+ MPs, CD31+/annexin V+ MPs, and decreased level of CD62E+ MPs in T2DM patients with asymptomatic coronary atherosclerosis in comparison with those who had no asymptomatic atherosclerosis. Using multivariate log regression analysis, BMI (odds ratio [OR] = 1.04, p = 0.001), LDL-C (OR = 1.05, p = 0.046), hs-CRP (OR = 1.07, p = 0.044), osteoprotegerin (OR = 1.07, p = 0.026), CD62E+ MPs (OR = 1.07, p = 0.001) and CD31+/annexin V+ MPs (OR = 1.12, p = 0.003) were determined independent predictive factors of asymptomatic atherosclerosis in T2DM patients. Conclusion: Circulating levels of MP originated from apoptotic endothelial cell-derived were significantly increased in diabetic patients as compared with normal subjects, but level of activated endothelial cell-derived MPs was lower than in healthy volunteers. Among T2DM patients, an increased level of CD31+/annexin V+ MPs and decreased CD62E+ MPs were significantly associated with asymptomatic atherosclerosis.Keywords
This publication has 28 references indexed in Scilit:
- Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity statusJournal of Thrombosis and Thrombolysis, 2013
- Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive proteinMolecular Biology Reports, 2013
- Osteoprotegerin as a Marker of Atherosclerosis in Diabetic PatientsInternational Journal of Endocrinology, 2013
- Microparticles in AngiogenesisCirculation Research, 2011
- The role of microvesicles in tissue repairOrganogenesis, 2011
- Endothelial microparticles in patients with insulin resistanceDiabetes & Metabolism, 2009
- Noninvasive Coronary Artery ImagingCirculation, 2008
- Cardiovascular Prevention in Patients with Diabetes and PrediabetesHerz, 2008
- Microparticles and type 2 diabetesDiabetes & Metabolism, 2008
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985